Dianthus Therapeutics | MGTA - Current Assets


Dianthus Therapeutics reported $413.82M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Celltrion KRW 5.54T 291.68B Sep/2025
Cspc Pharmaceutical CNY 22.61B 721.94M Jun/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 35.54M 2.13M Jun/2025
Moderna USD 6.6B 427M Sep/2025
Neuren Pharmaceuticals AUD 320.25M 79.08M Jun/2025
Organigram Holdings CAD 284.9M 7.11M Sep/2025
Organon & Co USD 4.7B 82M Sep/2025
Pharma Mar EUR 242.88M 6.52M Sep/2025
Qiagen NV USD 2.53B 711.95M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Sartorius EUR 1.72B 449M Sep/2025
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Tilray USD 688.63M 2.34M Mar/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025
Zz Pientze Pharmaceu CNY 10.7B 1.59B Sep/2025